Netherlands
# |
Name |
Inventory |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 12.02 M
|
Dec. 31, 2023 | USD 13.23 | -4.06% |
|
Netherlands |
|
2 |
USD 0.00
|
Dec. 31, 2023 | USD 0.98 | -1.01% |
|
Netherlands |
|
3 |
USD 0.00
|
Dec. 31, 2023 | USD 39.01 | -3.56% |
|
Netherlands |
|
4 |
USD 0.00
|
Dec. 31, 2023 | USD 23.67 | -3.70% |
|
Netherlands |
|
5 |
USD 0.00
|
Dec. 31, 2023 | USD 16.00 | -2.50% |
|
Netherlands |
|
6 |
USD 0.00
|
Dec. 31, 2023 | USD 2.26 | -0.44% |
|
Netherlands |
The Clinical Trials company in Netherlands with the highest Inventory is uniQure N.V. (NasdaqGS: QURE) at USD 12.02 M.
The Clinical Trials company in Netherlands with the lowest Inventory is ProQR Therapeutics N.V. (NasdaqCM: PRQR) at USD 0.00.
The top 10 Clinical Trials companies in Netherlands by Inventory are uniQure N.V., LAVA Therapeutics N.V., Merus N.V., NewAmsterdam Pharma Company N.V., Pharvaris N.V. and ProQR Therapeutics N.V..
The bottom 10 Clinical Trials companies in Netherlands by Inventory are ProQR Therapeutics N.V., Pharvaris N.V., NewAmsterdam Pharma Company N.V., Merus N.V., LAVA Therapeutics N.V. and uniQure N.V..